Infectious Diseases / Bacteria / Viruses News

1. Scientists discover skincare compound that kills drug-resistant bacteria

   A popular Korean skincare ingredient may be far more powerful than anyone realized. Scientists have discovered that madecassic acid—derived from the herb Centella asiatica—can stop antibiotic-resistant bacteria in their tracks, including dangerous strains of E. coli. By targeting a bacterial protein that humans don’t have, the compound disrupts the microbes’ ability to survive, making it a promising new type of antibiotic.

2. Scientists discover bacteria can “explode” to spread antibiotic resistance

   Scientists have uncovered a surprising twist in how bacteria share genes—including those that spread antibiotic resistance. Tiny virus-like particles called gene transfer agents (GTAs), once ancient viral invaders, have been repurposed by bacteria into delivery systems that shuttle DNA between neighboring cells. The study reveals a key control hub of three genes, dubbed LypABC, that triggers bacterial cells to burst open and release these DNA-packed couriers.

3. The dirtiest thing in public bathrooms isn’t the toilet seat

   Public restrooms might seem like a germ nightmare, but the real risks aren’t always where you think. While toilet seats can carry bacteria, viruses, and even parasite traces, studies show they’re often cleaner than high-touch surfaces like door handles and flush levers. The biggest hidden threat comes from “toilet plumes”—tiny germ-filled droplets launched into the air when flushing without a lid—and from poor hand hygiene.

4. Hidden weak spots in HIV and Ebola revealed with breakthrough nanodisc technology

   A new nanodisc-based platform lets scientists study viral proteins in a form that closely mimics real viruses, revealing how antibodies truly recognize them. This approach uncovered hidden interactions in viruses like HIV and Ebola that traditional methods missed. By recreating the virus’s membrane environment, researchers can better understand how immune defenses work. The technique could speed up the development of more effective vaccines.

5. Scientists finally crack mystery of rare COVID vaccine blood clots

   Researchers have uncovered why a rare blood clotting disorder can occur after certain COVID-19 vaccines or adenovirus infections. The immune system can mistakenly target a normal blood protein (PF4) after confusing it with a viral protein. This triggers clotting in extremely rare cases. The breakthrough means vaccines can now be redesigned to avoid this reaction while staying effective.

6. This diet could slash cholera infections by up to 100x

   A surprising new study reveals that what you eat could play a powerful role in fighting cholera, a deadly diarrheal disease. Researchers found that diets rich in certain proteins—especially casein from dairy and wheat gluten—can dramatically reduce the ability of cholera bacteria to take hold in the gut, in some cases cutting infection levels by up to 100 times. These proteins appear to disable a key “weapon” the bacteria use to attack other microbes and dominate the gut environment.

7. A drug already in trials may finally stop hepatitis E

   Scientists have identified a potential new weapon against hepatitis E, a virus with no approved treatment and tens of thousands of deaths each year. The drug bemnifosbuvir, currently in trials for hepatitis C, was found to block the virus from replicating by disrupting its genetic machinery. Tests in cells and animals showed strong effectiveness without harming healthy tissue. If ongoing trials succeed, the drug could soon be repurposed for hepatitis E.

8. This new test could transform UTI treatment with same-day results

   A breakthrough urine test could dramatically speed up how doctors treat urinary tract infections, identifying the right antibiotic in under six hours instead of waiting days. By testing directly from urine—skipping the usual lab culturing step—the method quickly shows which drugs stop bacterial growth and which don’t. In trials involving hundreds of patient samples, the test proved highly accurate, matching standard methods in over 96% of cases.